or Try an Advanced Search...

    Technical Analysis for QLGN - Qualigen Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.28 -0.07% 0.00
    QLGN closed down 1.65 percent on Wednesday, May 8, 2024, on approximately normal volume.
    Earnings due: May 14
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical QLGN trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish -0.07%
    Gapped Up Strength -0.07%
    Down 3 Days in a Row Weakness -0.07%
    New 52 Week Closing Low Bearish -1.72%
    Wide Bands Range Expansion -1.72%
    20 DMA Resistance Bearish -4.40%
    Inside Day Range Contraction -4.40%
    Wide Bands Range Expansion -4.40%
    20 DMA Resistance Bearish -6.98%
    Pocket Pivot Bullish Swing Setup -6.98%
    Older End-of-Day Signals for QLGN ...

       Recent Intraday Alerts

    Alert Time
    2x Volume Pace about 1 hour ago
    1.5x Volume Pace about 1 hour ago
    Up 3% about 1 hour ago
    Down 1% about 1 hour ago
    Up 2% about 1 hour ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    QLGN Chart by TradingView
    Basic chart:

    Profile

    Qualigen is a biotechnology company focused on developing novel products for the treatment and testing of cancer and infectious diseases. Its current commercial product is the FastPack rapid diagnostic testing system. This "Laboratory in a Pouch" is installed in physician offices, clinics and small hospitals around the world, and quickly detects diseases and medical conditions at the point-of-care. Since its inception almost 20 years ago, FastPack has generated more than $100 million in commercial sales. Qualigen's worldwide distributor for FastPack is Sekisui Diagnostics, a subsidiary of a multibillion-dollar Japanese chemical and technology company. Sekisui owns approximately 15.8% of Qualigen's outstanding common shares.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Chemical Disease Infectious Diseases Clinic Medical Test Novel Products

    Is QLGN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared DuraGraft™
    Apr 10 Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
    Jan 11 Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
    Nov 27 QLGN: Dosing Begins in Phase 1 Trial of QN-302…
    Nov 14 Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
    Nov 7 Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
    See more QLGN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.25
    52 Week Low 0.27
    Average Volume 71,727
    200-Day Moving Average 0.68
    50-Day Moving Average 0.36
    20-Day Moving Average 0.30
    10-Day Moving Average 0.29
    Average True Range 0.03
    RSI (14) 34.21
    ADX 17.07
    +DI 15.75
    -DI 15.68
    Chandelier Exit (Long, 3 ATRs) 0.30
    Chandelier Exit (Short, 3 ATRs) 0.37
    Upper Bollinger Bands 0.34
    Lower Bollinger Band 0.27
    Percent B (%b) 0.17
    BandWidth 24.54
    MACD Line -0.02
    MACD Signal Line -0.03
    MACD Histogram 0.0017
    Fundamentals Value
    Market Cap 1.45 Million
    Num Shares 5.18 Million
    EPS -4.07
    Price-to-Earnings (P/E) Ratio -0.07
    Price-to-Sales 0.56
    Price-to-Book 0.35
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.31
    Resistance 3 (R3) 0.32 0.31 0.31
    Resistance 2 (R2) 0.31 0.30 0.31 0.31
    Resistance 1 (R1) 0.29 0.29 0.29 0.29 0.30
    Pivot Point 0.29 0.29 0.28 0.28 0.29
    Support 1 (S1) 0.27 0.28 0.27 0.27 0.26
    Support 2 (S2) 0.26 0.27 0.26 0.25
    Support 3 (S3) 0.25 0.26 0.25
    Support 4 (S4) 0.25